NEXT GENERATION PROBIOTICS FROM NOVEL DRUGS TO FUTURE THERAPEUTICS (HB 2026)
Idioma: inglés
Editorial: TAYLOR & FRANCIS NP EXCLUSIVE(CBS), 2026
- Tapa dura
- Nuevo

Librería: UK BOOKS STORE, London, London, Reino UnidoUK BOOKS STORE
Vendedor de IberLibro desde 11 de marzo de 2024
Condición: Nuevo
EUR 237,11
Cantidad disponible: 11 disponibles
Añadir al carritoDescripción del artículo del vendedor
Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
N° de ref. del artículo CvS 9781032516387
- Título
- NEXT GENERATION PROBIOTICS FROM NOVEL DRUGS TO FUTURE THERAPEUTICS (HB 2026)
- Autor
- GHAZANFAR S
- Editorial
- TAYLOR & FRANCIS NP EXCLUSIVE(CBS)
- Año de publicación
- 2026
- Estado
- New
- Encuadernación
- Encuadernación de tapa dura
- Idioma
- inglés
- ISBN 10
- 1032516380
- ISBN 13
- 9781032516387
- Edición
- Edición Internacional
Next Generation Probiotics: From Novel Drugs to Future Therapeutics provides a comprehensive and cutting-edge exploration of probiotics as powerful therapeutic agents. With the rapid advancements in the field, this book offers a deep dive into how probiotics are evolving beyond traditional uses, addressing complex health conditions and diseases in modern medicine. By combining the latest scientific research with practical applications, this book equips researchers, clinicians, and healthcare professionals with the knowledge needed to incorporate probiotics into clinical practice and future therapeutic strategies.
The book covers a wide range of essential topics, including:
- Probiotic mechanisms and the chemical characterization of bioactive compounds derived from probiotics
- The emerging role of probiotics in gut-brain interactions and psychobiotics for mental health
- Probiotic-based drug development and their applications in personalized medicine
- Probiotics in the prevention and treatment of gastrointestinal disorders, metabolic diseases, and cancer
- The integration of next-generation sequencing and machine learning in optimizing probiotic therapies
- Probiotics in functional foods and their potential to alleviate lactose intolerance
- Applications in animal health, focusing on terrestrial and aquatic animals
This book stands out by offering an exhaustive examination of probiotics in therapeutic applications, providing real-world examples and insights into how these microorganisms are reshaping modern medicine. Next Generation Probiotics is a must-read for researchers, clinicians, and healthcare professionals interested in the future of probiotics as a therapeutic tool for a wide range of health challenges.
“Sinopsis” puede pertenecer a otra edición de este título.
Acerca del autor
Prof Charles Oluwaseun Adetunji
Prof Charles Oluwaseun Adetunji is presently a faculty member at the Microbiology Department, Faculty of Science, Edo State University Uzairue, Edo State, Nigeria, where he utilized the application of biological techniques and microbial bioprocesses for the actualization of sustainable development goals and agrarian revolution, through quality teaching, research, and community development. He was formally the Acting Director of Intellectual Property and Technology Transfer, the Head of the Department of Microbiology, Sub Dean of the Faculty of Science, and currently the Chairman Grant Committee and immediate Dean of Faculty of Science, and now the Director of Research and Innovation at EDSU.
Dr. Shakira Ghazanfar
Dr. Shakira Ghazanfar is working as Senior Scientific Officer at PARC, Islamabad, Pakistan since 2007. She did her Ph.D in Microbiology from Quaid-i-Azam University Islamabad Pakistan. Her area of research is development and commercialization of the TARGET BASED Probiotic Products based on AI/DL/ML. She is regarded among the pioneers, who have initiated Animal Probiotic Research to improve livestock productivity in Pakistan. She is the Main Organizer (100 plus training organizer) of the Training/Workshops/Webinars in her Department. Published more than 100+ research papers (400 plus impact factor), 50+ book chapters, and Main editor of CRC press USA and Springer Nature publishers' books. She is Guest Editor in well-known Journals. She co/supervised/supervising research of 20+ PhD, 100+ MPhil/BS students. She has published widely in the field of AI/ML/DL and food microbiology, drug discovery, nutraceuticals and functional foods with specialization in probiotics-based food/feed and probiotic related anticancer agents.
Alessandro Di Cerbo
Professor Alessandro Di Cerbo, BSc, MSc, PhD, PD, is an Associate Professor of Veterinary Pharmacology and Toxicology at the University of Camerino, Italy, School of Biosciences and Veterinary Science. He has published 133 peer-reviewed papers (h-index: Google Scholar 30, Scopus 27) with 2,789 Google Scholar and 2,088 Scopus citations, edited one monograph, and authored four book chapters. Eligible to serve as a Full Professor since January 2022 and an Associate Professor since November 2020 (Italian Ministry of Education, University, and Research), he is an editorial board member or Associate Editor for several prominent journals, including Frontiers in Veterinary Science and BMC Veterinary Research. His research interests focus on pharmacological residues in animal-derived foods, animal well-being, nutraceutical efficacy, toxicological evaluations, antimicrobial activity of natural products, and nanotechnology applications in food and drugs.
Ghulam Muhammad Ali
Dr. Ghulam Muhammad Ali, Chairman of the Pakistan Agricultural Research Council (PARC), is a distinguished scientist in molecular biology and biotechnology with a PhD from the University of Liverpool and postdoctoral fellowships from Canada and Japan. He has held pivotal roles at PARC, including Director General of NARC and Member of Plant Sciences Division. Dr. Ali has published around 400 papers, led numerous research projects, and established the National Institute for Genomics and Advanced Biotechnology (NIGAB). He pioneered innovations like aeroponic potato seed production, virus-free banana varieties, and Green Super Rice development. Recognized with multiple awards, Dr. Ali’s groundbreaking work in crop improvement and food security underscores his impactful career.
Wajya Ajmal
Wajya Ajmal is an accomplished bioinformatics professional, who serves as a Scientific Officer at the National Institute for Genomics and Advanced Biotechnology (NIGAB), Islamabad, Pakistan, a role held since April 2022. With over eight years of experience in the biotechnology industry, including prior work as an Assistant Scientific Officer at NIGAB, she possess expertise in sequence analysis, bioinformatics, Python, systems biology, and Perl. A strong research background supports their work, including a Master of Philosophy (MPhil) in Bioinformatics from Quaid-i-Azam University (2012–2014) and a Bachelor of Science (BS) in Bioinformatics from COMSATS University Islamabad (2007–2011). Wajya’s career reflects a robust commitment to advancing genomics and biotechnology through innovative research and technical proficiency.
Muhammad Naeem Riaz
Naeem Riaz is the Head of the National Institute for Genomics and Advanced Biotechnology (NIGAB) at the Pakistan Agricultural Research Council (PARC), Islamabad. A seasoned expert in molecular biology, biotechnology, and genomics, he has made significant contributions to agricultural research and innovation. With extensive experience in genomics, bioinformatics, and molecular techniques, Naeem has led pioneering research projects and spearheaded the development of advanced biotechnological solutions to enhance crop productivity and food security. Under his leadership, NIGAB has emerged as a leading biotech center, fostering innovation and training skilled researchers. Naeem Riaz's dedication to advancing biotechnology continues to drive impactful contributions to Pakistan's agricultural sector.
“Acerca de” puede pertenecer a otra edición de este título.
UK BOOKS STORE
London, London, Reino Unido
Vendedor de IberLibro desde 11 de marzo de 2024
Tarifas de envío de Reino Unido a Estados Unidos de America
| Artículo | De 5 a 10 días hábiles | De 4 a 7 días hábiles |
|---|---|---|
| Primer artículo | EUR 4,78 | EUR 10,65 |
Métodos de pago
Información empresarial del vendedor
URBAN BOOK LIMITED
71-75 Shelton Street, Covent Garden
London, Reino Unido WC2H 9JQ
Derecho al desistimiento
Si es un consumidor, puede rescindir el contrato de acuerdo con lo siguiente. Por consumidor se entiende cualquier persona física que actúe con fines ajenos a su actividad comercial, empresarial, oficio o profesión.
Información sobre el derecho de desistimiento
Derecho legal de desistimiento
Tiene derecho a rescindir este contrato en un plazo de 14 días sin dar ningún motivo.
El periodo de desistimiento vencerá a los 14 días desde que usted, o un tercero que no sea el transportista e indicado por usted, adquiera la posesión física del último bien o del último lote o pieza.
Para ejercer el derecho de desistimiento, complete de forma electrónica y envíe una declaración clara en nuestro sitio web, desde "Mis compras" en "Mi cuenta". Le enviaremos sin demora un acuse de recibo de dicho desistimiento a través de un soporte duradero (por ejemplo, por correo electrónico).
Para cumplir con el plazo de desistimiento, basta con que envíe su comunicación relativa al ejercicio del derecho de desistimiento antes de que venza el periodo de desistimiento.
Efectos del desistimiento
Si rescinde este contrato, le reembolsaremos todos los pagos que hayamos recibido de usted, incluidos los gastos de envío (excepto los gastos adicionales que surjan si elige un tipo de envío que no sea el tipo de envío estándar más económico que ofrecemos).
Podemos hacer una deducción del reembolso por la pérdida de valor de cualquier bien suministrado, si la pérdida es el resultado de una manipulación innecesaria por su parte.
Efectuaremos el reembolso sin demoras indebidas y, a más tardar, 14 días después de que se nos informe de su decisión de rescindir este contrato.
Efectuaremos el reembolso utilizando el mismo medio de pago que utilizó para la transacción inicial, a menos que haya acordado expresamente lo contrario; en cualquier caso, no incurrirá en ningún cargo como resultado de dicho reembolso.
Podremos retener el reembolso hasta que hayamos recibido los bienes o hasta que nos haya presentado una prueba de que los ha devuelto, lo que ocurra primero.
Deberá devolver los bienes o entregarlos a UK BOOKS STORE, London, United Kingdom, sin demoras indebidas y, en cualquier caso, en un plazo máximo de 14 días a partir del día en que nos comunique su desistimiento del presente contrato. El plazo se cumple si devuelve la mercancía antes de que venza el periodo de 14 días. Tendrá que asumir los gastos directos de devolución de los bienes. Usted solo es responsable de la disminución del valor de los bienes como resultado de una manipulación distinta a la necesaria para establecer la naturaleza, las características y el funcionamiento de los bienes.
Excepciones al derecho de desistimiento
El derecho de desistimiento no se aplica a lo siguiente:
- La entrega de periódicos, diarios o revistas, con la excepción de los contratos de suscripción; y
- El suministro de contenido digital que no se proporcione en un soporte tangible (por ejemplo, en un CD o DVD) si, al hacer el pedido, aceptó que podíamos empezar a entregarlo y que no podría desistir una vez iniciada la entrega.